亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Overall survival and PD-L1 expression in patients with recurrent or metastatic head and neck cancer treated with nivolumab

医学 无容量 内科学 肿瘤科 头颈部癌 头颈部鳞状细胞癌 无进展生存期 接收机工作特性 癌症 临床终点 免疫组织化学 对数秩检验 PD-L1 生存分析 胃肠病学 总体生存率 免疫疗法 临床试验
作者
Isaku Okamoto,Hiroki Sato,Kiyoaki Tsukahara
出处
期刊:Auris Nasus Larynx [Elsevier BV]
卷期号:47 (4): 676-686 被引量:13
标识
DOI:10.1016/j.anl.2020.04.001
摘要

Objective Our facility measures programmed cell death ligand 1 (PD-L1) expression in all patients before administering nivolumab. The aim of the present study is to clarify the association between overall survival (OS) and PD-L1 expression. Patients and Methods Subjects in this study were 52 patients with R/M-HNC cancer (45 men, 7 women) administered nivolumab in our facility between June 1, 2017 and January 31, 2019. Mean age was 62.2 years (median, 65 years; range, 28–81 years). Histopathological type was squamous cell carcinoma (SCC) in 48 cases, and non-SCC in 4 cases. We set OS as the primary endpoint and progression-free survival (PFS), overall response rate (ORR), association of OS and PD-L1 expression and association of PFS and PD-L1 expression as secondary endpoints. The cut-off for PD-L1 expression was set using the receiver operating characteristic (ROC) curve. We compared OS, PES and ORR using this PD-L1 cut-off for all patients and for the SCC group. OS and PFS were calculated using Kaplan-Meier methods. The log-rank test was used for statistical analysis, with values of p < 0.05 taken as significant. For PD-L1 immunohistochemistry assays, Dako 28-8 antibody was used. Results In the all-patients group, median OS was 9.6 months and 1-year OS rate was 40.4%. Median PFS was 4.0 months and 1-year PFS rate was 37.8%. The cut-off value of PD-L1 expression for OS was 40% for all patients and the SCC group. When PD-L1 expression was ≥40%, OS was significantly better in both all patients and the SCC group (p = 0.004, 0.007). The cut-off value of PD-L1 expression for PFS was also 40%. When PD-L1 expression was ≥40%, PFS was better in all patients and the SCC group (P = 0.003, 0.009). In the all-patients group, ORR was 19.2% and disease control rate (DCR) was 44.2%. When PD-L1 expression was ≥40%, ORR was 44.4% and DCR 83.3%. Conclusion In the present study, when PD-L1 expression was high (≥40%), OS was significantly better (p = 0.004). This finding has not been reported in other research on R/M-HNC. PFS and ORR were also better with high PD-L1 expression. Regarding patterns of progression with a PD-L1 expression cut-off of 40%, hyperprogression was significantly more frequent for PD-L1 expression <40% (p = 0.039). Therefore, high PD-L1 expression could offer a predictor of prognosis and efficacy for nivolumab. The present findings may prove useful in considering treatment strategies.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
LEESO完成签到,获得积分10
2秒前
edisonyan完成签到 ,获得积分10
5秒前
14秒前
哈哈发布了新的文献求助10
17秒前
量子星尘发布了新的文献求助10
32秒前
34秒前
恻隐发布了新的文献求助10
39秒前
爆米花应助yzh2004采纳,获得30
48秒前
55秒前
1分钟前
1分钟前
yzh2004发布了新的文献求助30
1分钟前
努力努力再努力完成签到,获得积分10
1分钟前
幸识完成签到 ,获得积分10
1分钟前
领导范儿应助二丙采纳,获得10
1分钟前
1分钟前
二丙发布了新的文献求助10
1分钟前
科研通AI5应助幸识采纳,获得30
1分钟前
轩轩轩轩完成签到 ,获得积分10
1分钟前
二丙完成签到,获得积分10
1分钟前
传奇3应助99253761采纳,获得30
1分钟前
顾矜应助科研通管家采纳,获得10
1分钟前
深情安青应助体贴的雪卉采纳,获得10
2分钟前
夏瑞发布了新的文献求助10
2分钟前
A水暖五金批发张哥完成签到,获得积分10
2分钟前
yzh2004完成签到,获得积分20
2分钟前
负责吃饭发布了新的文献求助20
2分钟前
夏瑞完成签到,获得积分10
2分钟前
可爱的函函应助kkk采纳,获得10
2分钟前
量子星尘发布了新的文献求助10
2分钟前
2分钟前
2分钟前
2分钟前
ceeray23发布了新的文献求助20
2分钟前
万能图书馆应助拆鱼鱼采纳,获得10
3分钟前
3分钟前
123完成签到 ,获得积分10
3分钟前
3分钟前
Augusterny完成签到 ,获得积分10
3分钟前
量子星尘发布了新的文献求助10
3分钟前
高分求助中
Picture Books with Same-sex Parented Families: Unintentional Censorship 1000
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 310
宽量程高线性度柔性压力传感器的逆向设计 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3980849
求助须知:如何正确求助?哪些是违规求助? 3524642
关于积分的说明 11222225
捐赠科研通 3262101
什么是DOI,文献DOI怎么找? 1801054
邀请新用户注册赠送积分活动 879591
科研通“疑难数据库(出版商)”最低求助积分说明 807424